These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9129006)

  • 1. Interferon adjuvant therapy of melanoma.
    Kirkwood JM; Wazer D; Rosenstein M
    Cancer; 1997 May; 79(9):1843-6. PubMed ID: 9129006
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma.
    Grob JJ; Dreno B; de la Salmonière P; Delaunay M; Cupissol D; Guillot B; Souteyrand P; Sassolas B; Cesarini JP; Lionnet S; Lok C; Chastang C; Bonerandi JJ
    Lancet; 1998 Jun; 351(9120):1905-10. PubMed ID: 9654256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant interferon in the treatment of melanoma.
    Middleton MR
    Br J Cancer; 1999 Aug; 80(11):1679-80. PubMed ID: 10468281
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant interferon alfa-2b for high-risk melanoma.
    Retsas S
    J Clin Oncol; 1996 Jun; 14(6):1968-9. PubMed ID: 8656272
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant interferon for stage II melanoma.
    Haluska FG
    J Clin Oncol; 1998 Sep; 16(9):3205-6. PubMed ID: 9738597
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical prognostic factors in adjuvant melanoma trial.
    Nathanson L
    J Clin Oncol; 1996 Jun; 14(6):1967-8. PubMed ID: 8656271
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of adjuvant interferon study in WHO melanoma programme.
    Cascinelli N; Bufalino R; Morabito A; Mackie R
    Lancet; 1994 Apr; 343(8902):913-4. PubMed ID: 7908370
    [No Abstract]   [Full Text] [Related]  

  • 8. Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.
    Johnson DM; Hayat SQ; Burton GV
    J Rheumatol; 1999 Apr; 26(4):1009-10. PubMed ID: 10229440
    [No Abstract]   [Full Text] [Related]  

  • 9. [High-dose interferon-alpha and adjuvant treatment of melanoma with poor prognosis: requiem for a drug marketing license?].
    Saiag P
    Ann Dermatol Venereol; 1999 Mar; 126(3):211-3. PubMed ID: 10394432
    [No Abstract]   [Full Text] [Related]  

  • 10. Where are we with adjuvant therapy of stage III and IV melanoma in 2009?
    Fecher LA; Flaherty KT
    J Natl Compr Canc Netw; 2009 Mar; 7(3):295-304. PubMed ID: 19401062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanoma.
    Messori A; Becagli P; Trippoli S; Tendi E
    Eur J Cancer; 1997 Aug; 33(9):1373-9. PubMed ID: 9337677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on "Perhaps not everyone knows that...", (Ann Oncol 2001; 12: 1186).
    Sulkes A; Schachter J
    Ann Oncol; 2002 Apr; 13(4):637. PubMed ID: 12056717
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant therapy for malignant melanoma.
    Stoutenburg JP; Schrope B; Kaufman HL
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adjuvant interferon-alpha therapy of malignant melanoma. Position of the Dermatologic Oncology Working Group].
    Hauschild A; Dummer R; Garbe C; Kaufmann R; Schadendorf D; Soyer HP; Stadler R; Tilgen W
    Hautarzt; 1998 Mar; 49(3):167-9. PubMed ID: 9565782
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of adjuvant therapy in cutaneous melanoma.
    Sondak VK
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):421-6. PubMed ID: 12113108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant interferon for melanoma.
    Wheatley K; Ives N
    Ann Oncol; 2002 Aug; 13(8):1319-20; author reply 1320. PubMed ID: 12181258
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on adjuvant interferon therapy for high-risk melanoma.
    Agarwala SS; Kirkwood JM
    Oncology (Williston Park); 2002 Sep; 16(9):1177-87; discussion 1190-2, 1197. PubMed ID: 12380946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant IFN alpha2 therapy of melanoma.
    Kirkwood JM
    Lancet; 1998 Jun; 351(9120):1901-3. PubMed ID: 9654253
    [No Abstract]   [Full Text] [Related]  

  • 19. [After removal of a malignant melanoma. Enhancing the immune system!].
    MMW Fortschr Med; 1999 Nov; 141(44):66. PubMed ID: 10912153
    [No Abstract]   [Full Text] [Related]  

  • 20. The adjuvant treatment of malignant melanoma.
    Reintgen D; Kirkwood J
    J Fla Med Assoc; 1997 Mar; 84(3):147-52. PubMed ID: 9143164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.